Somerville, MA, United States of America

Michael Doherty

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Michael Doherty: Innovator in Extracellular Vesicle Research

Introduction

Michael Doherty is a prominent inventor based in Somerville, MA (US), known for his significant contributions to the field of extracellular vesicle research. With a total of 4 patents, he has made strides in developing methods that enhance the preparation and loading of extracellular vesicles for therapeutic applications.

Latest Patents

Doherty's latest patents include innovative techniques such as "Loading of extracellular vesicles through imparting of mechanical shear," which discloses methods for loading extracellular vesicles with payload molecules via homogenization. Another notable patent is "Process for preparing extracellular vesicles," which relates to multistep chromatographic methods for preparing high-quality extracellular vesicles (EVs) on a large scale. These methods are designed to enable the preparation of EVs for therapeutic and diagnostic applications, as well as the isolation and sub-fractionation of EVs with specific properties for targeted use.

Career Highlights

Throughout his career, Michael Doherty has worked with notable companies such as Axcella Health Inc. and Lonza Sales AG. His work has been instrumental in advancing the understanding and application of extracellular vesicles in various medical fields.

Collaborations

Doherty has collaborated with several professionals in his field, including Michael Hamill and Brett Adam Boghigian. These collaborations have contributed to the development of innovative solutions in extracellular vesicle research.

Conclusion

Michael Doherty's work in the field of extracellular vesicles showcases his dedication to innovation and research. His patents and collaborations highlight his role as a key figure in advancing therapeutic applications of EVs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…